We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+1.87%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$1.51B
AUM Growth
-$409M
Cap. Flow
-$427M
Cap. Flow %
-28.33%
Top 10 Hldgs %
28.77%
Holding
232
New
58
Increased
45
Reduced
50
Closed
68

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$31.1M
2
TDG icon
TransDigm Group
TDG
+$24M
3
MRK icon
Merck
MRK
+$18.9M
4
MSFT icon
Microsoft
MSFT
+$17.8M
5
ON icon
ON Semiconductor
ON
+$16.8M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$41.5M
2
AGNC icon
AGNC Investment
AGNC
+$37.4M
3
CLR
CONTINENTAL RESOURCES INC.
CLR
+$35M
4
WPX
WPX Energy, Inc.
WPX
+$33.5M
5
AMZN icon
Amazon
AMZN
+$30.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.84%
2 Technology 16.02%
3 Financials 15.78%
4 Communication Services 15.65%
5 Consumer Discretionary 11.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NRO
126
Neuberger Real Estate Securities Income Fund Inc
NRO
$172M
$747K 0.05%
145,733
-39,344
-21% -$199K
DHF
127
BNY Mellon High Yield Strategies Fund
DHF
$165M
$710K 0.05%
+211,300
New +$693K
GER
128
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
$710K 0.05%
+10,967
New +$690K
DSL
129
DoubleLine Income Solutions Fund
DSL
$1.17B
$708K 0.05%
+37,300
New +$693K
PHT
130
DELISTED
Pioneer High Income Fund
PHT
$708K 0.05%
+69,300
New +$694K
CVRS
131
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$707K 0.05%
1,012,054
-37,800
-4% -$31.8K
CLVS
132
DELISTED
Clovis Oncology, Inc.
CLVS
$702K 0.05%
15,800
-11,700
-43% -$412K
FFC
133
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$739M
$697K 0.05%
+37,000
New +$726K
BAX icon
134
Baxter International
BAX
$12.3B
$683K 0.05%
15,400
-83,600
-84% -$3.87M
DSE
135
DELISTED
Duff & Phelps Select MLP and Midstream Energy Fund Inc.
DSE
$657K 0.04%
+8,670
New +$644K
DHY
136
UBS Asset Management High Yield Credit Fund
DHY
$227M
$655K 0.04%
+245,342
New +$609K
UTHR icon
137
United Therapeutics
UTHR
$21.5B
$645K 0.04%
+4,500
New +$575K
INDA icon
138
iShares MSCI India ETF
INDA
$6.45B
$619K 0.04%
23,100
-288,500
-93% -$8.02M
ALXN
139
DELISTED
Alexion Pharmaceuticals
ALXN
$600K 0.04%
+4,900
New +$600K
CAF
140
Morgan Stanley China A Share Fund
CAF
$242M
$596K 0.04%
35,100
– –
PHF
141
DELISTED
Pacholder High Yield
PHF
$560K 0.04%
77,800
+13,000
+20% +$91.5K
BLUE
142
DELISTED
bluebird bio
BLUE
$555K 0.04%
+695
New +$552K
ELOS
143
DELISTED
Syneron Medical Ltd
ELOS
$543K 0.04%
+64,700
New +$507K
NXTM
144
DELISTED
NxStage Medical Inc.
NXTM
$532K 0.04%
+20,300
New +$502K
ETO
145
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$499M
$514K 0.03%
+24,676
New +$510K
CET
146
Central Securities Corp
CET
$1.65B
$475K 0.03%
21,800
+5,100
+31% +$108K
KERX
147
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$461K 0.03%
78,600
+45,000
+134% +$246K
JMLP
148
DELISTED
NUVEEN ALL CAP ENERGY MLP OPPORTUNITIES FUND
JMLP
$426K 0.03%
+42,400
New +$402K
ERC
149
Allspring Multi-Sector Income Fund
ERC
$249M
$409K 0.03%
+31,900
New +$403K
FTF
150
Franklin Limited Duration Income Trust
FTF
$228M
$396K 0.03%
+32,900
New +$394K
4 5
6
7 8

Similar funds

ACG
Allen Capital Group Grand Island, Nebraska $1.23B AUM 19.04% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
CCFCSB
Cape Cod Five Cents Savings Bank Orleans, Massachusetts $1.23B AUM
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
OA
Oxbow Advisors Austin, Texas $1.23B AUM 23.59% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.23B AUM 15.23% 1-Year Est. Return
ZA
Zazove Associates Incline Village, Nevada $1.22B AUM 1.92% 1-Year Est. Return
WVUF
West Virginia University Foundation Morgantown, West Virginia $1.22B AUM 21.82% 1-Year Est. Return

Clough Capital Partners's Q4 2016 Portfolio in Review

As of Q4 2016, Clough Capital Partners held 232 positions worth $1.51B, down 21% from $1.92B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Clough Capital Partners withdrew a net $427M in Q4 2016, closing 68 positions and reducing 50 holdings. Its most notable exit was AGNC Investment, an estimated $37.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

Against the trend, Clough Capital Partners opened a new position in TransDigm Group worth $22.7M.

  • Clough Capital Partners's largest Q4 2016 buy was TransDigm Group: 91,300 shares worth $22.7M.
  • Clough Capital Partners added most to Apple in Q4 2016, an estimated $31.1M increase.
  • Clough Capital Partners's biggest Q4 2016 reduction was Alphabet (Google) Class C, cutting an estimated $41.5M.
  • Clough Capital Partners fully exited AGNC Investment in Q4 2016, selling an estimated $37.4M.
  • Clough Capital Partners's ten largest holdings make up 29% of its $1.51B portfolio in Q4 2016.
  • Clough Capital Partners opened 58 new positions and closed 68 in Q4 2016.
  • Clough Capital Partners's portfolio value fell 21% quarter-over-quarter to $1.51B.

Based on Clough Capital Partners's 13F filing for Q4 2016, filed 14 Feb 2017.